市场调查报告书
商品编码
1411316
病理检测设备市场:按设备、应用和最终用户划分 - 2023-2030 年全球预测Pathology Instruments Market by Instruments (Centrifuges, Cytometers, Digital Pathology Solutions), Application (Anatomic Pathology, Clinical Pathology, Molecular Pathology), End-User - Global Forecast 2023-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2022年病理检测设备市场规模为70.3亿美元,2023年达74.6亿美元,预计2030年将达120.7亿美元,复合年增长率为6.98%。
全球病理检测设备市场
主要市场统计 | |
---|---|
基准年[2022] | 70.3亿美元 |
预测年份 [2023] | 74.6亿美元 |
预测年份 [2030] | 120.7亿美元 |
复合年增长率(%) | 6.98% |
病理设备是用于检查组织和体液以诊断疾病的专用工具和设备。这些仪器包括用于切片组织标本的切片机、用于对细胞和组织成分进行颜色编码的组织染色系统以及用于测量特定血液和尿液样本标记物的分析仪。病理检测设备应用于组织病理学、细胞病理学、分子病理学、法医病理学等领域。全球慢性病数量的不断增加增加了对诊断服务的需求,因此需要引进高效的病理检测设备。此外,增加政府在医疗保健方面的支出以及对实施先进病理学解决方案的支持将导致对病理设施的投资增加,从而促进市场成长。然而,先进病理检测设备的高昂成本可能会阻碍普及。此外,与病理设备相关的错误和操作设备的困难可能对病理设备的普及构成进一步的挑战。然而,为了改善和简化病理设备的采用,主要企业正在投资将数位病理系统和设备与人工智慧和机器学习整合。这些系统可以处理大型资料集,提高诊断准确性并提高工作流程效率。此外,与医疗保健提供者合作开发将病理测试设备与其他医疗设备和电子健康记录连接起来的整合系统可以为该行业开闢新的成长途径。
区域洞察
以美国和加拿大为中心的美洲地区是医疗保健行业几家主要公司的所在地,因此建立了强大的医疗保健基础设施,从而推动了病理检测设备市场的成长。该地区也不断探索人工智慧(AI)、机器学习(ML)和巨量资料分析等先进数位技术,显着提高病理设备的功能和性能。欧盟 (EU) 对体外诊断的严格监管和成熟的医疗基础设施推动了市场的成长。私人和公共机构之间为提高诊断能力而进行的频繁合作导致了病理解决方案和设备的持续创新。亚太地区病理检测设备市场呈现快速成长,其中中国、日本和印度等国家引领扩张。由于大规模的医疗改革和医疗基础设施投资的增加,中国市场正在经历快速成长。此外,中国政府对公共卫生和预防保健措施的重视也刺激了病理服务需求的增加。
FPNV定位矩阵
FPNV定位矩阵对于评估病理检测设备市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对病理实验室设备市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵考察,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略,从而在市场上获得竞争优势。
1-市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2-市场开拓:我们深入研究利润丰厚的新兴市场并分析其在成熟细分市场的渗透率。
3- 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4-竞争评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5- 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1-病理检测设备市场的市场规模与预测是多少?
2-病理实验室设备市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些?
3-病理检测设备市场的技术趋势和法律规范是什么?
4-病理检测设备市场主要厂商的市场占有率为何?
5-进入病理检测设备市场合适的型态和策略手段是什么?
[197 Pages Report] The Pathology Instruments Market size was estimated at USD 7.03 billion in 2022 and expected to reach USD 7.46 billion in 2023, at a CAGR 6.98% to reach USD 12.07 billion by 2030.
Global Pathology Instruments Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2022] | USD 7.03 billion |
Estimated Year [2023] | USD 7.46 billion |
Forecast Year [2030] | USD 12.07 billion |
CAGR (%) | 6.98% |
Pathology instruments are specialized tools and equipment used in the examination of tissues and body fluids to diagnose diseases. These instruments include microtomes for slicing tissue specimens, histology stain systems for color-coding cells and tissue components, and analyzers that measure specific blood or urine sample markers. Pathology instruments are applied in histopathology, cytopathology, molecular pathology, and forensic pathology, among other fields. An increase in chronic diseases worldwide contributes to the need for diagnostic services and necessitates the deployment of highly efficient pathology instruments. Furthermore, growing healthcare expenditure by governments and support for deploying advanced pathology solutions can lead to increased investments in pathology facilities, aiding the growth of the market. However, the high costs of advanced pathology instruments may hinder their adoption. Additionally, errors associated with pathology instruments and difficulties in handling the instruments can further present challenges to the widespread utilization of pathology instruments. However, key players are investing in the integration of digital pathology systems and instruments with AI, and machine learning offers to improve and ease the adoption of pathology instruments. These systems can handle large data sets, improve diagnostic accuracy, and enhance workflow efficiency. Furthermore, collaborating with healthcare providers to develop integrated systems that connect pathology instruments with other medical devices and electronic health records can provide new avenues of growth for the industry.
Regional Insights
The Americas region, particularly the US and Canada, features a robust healthcare infrastructure characterized by the presence of several major players in the healthcare industry, which has driven the growth of the pathology instruments market. The region is also involved in the constant exploration of advanced digital technologies, including artificial intelligence (AI), machine learning (ML), and big data analytics, that have significantly enhanced the functionality and performance of pathology instruments. Stringent regulations by the European Union on in-vitro diagnostics and a well-established healthcare infrastructure foster market growth. Frequent collaboration between private and public entities to propel diagnostics capabilities has further led to constant innovations in pathology solutions and instruments. The Asia-Pacific region is exhibiting rapid growth in the pathology instruments market, with countries such as China, Japan, and India leading the expansion. China's market is burgeoning, fueled by large-scale healthcare reforms and growing investment in healthcare infrastructure. Additionally, the Chinese government's focus on public health and preventive healthcare measures adds to the increased demand for pathology services.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Pathology Instruments Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pathology Instruments Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Pathology Instruments Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Amos Scientific Pty. Ltd., Becton, Dickinson and Company, Bio SB Inc., Bio-Genex Laboratories, Bio-Rad Laboratories, Inc., BRAND GMBH + CO KG, Carl Zeiss AG, Danaher Corporation, Diapath S.p.A., Diatron Group by STRATEC SE, F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, Hamamatsu Photonics K.K., Hamilton Company, Hologic, Inc., Horiba Corporation, Illumina Inc., Jinan Olabo Technology Co., Ltd., Koninklijke Philips N.V., Merck KGaA, Mikroscan Technologies, Inc., Nihon Kohden Corporation, Olympus Corporation, PerkinElmer Inc., PHC Holdings Corporation, QIAGEN N.V., RWD Life Science Co., Ltd., Sakura Finetek Japan Co., Ltd., Shimadzu Corporation, Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., VOGEL MedTec GmbH, and Waters Corporation.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Pathology Instruments Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pathology Instruments Market?
3. What are the technology trends and regulatory frameworks in the Pathology Instruments Market?
4. What is the market share of the leading vendors in the Pathology Instruments Market?
5. Which modes and strategic moves are suitable for entering the Pathology Instruments Market?